Dual inhibition of TGFβ signaling and CSF1/CSF1R reprograms tumor-infiltrating macrophages and improves response to chemotherapy via suppressing PD-L1
-
Published:2022-09
Issue:
Volume:543
Page:215795
-
ISSN:0304-3835
-
Container-title:Cancer Letters
-
language:en
-
Short-container-title:Cancer Letters
Author:
Chen Tsung-Wei,
Hung Wei-Ze,
Chiang Shu-Fen,
Chen William Tzu-Liang,
Ke Tao-Wei,
Liang Ji-An,
Huang Chih-Yang,
Yang Pei-Chen,
Huang Kevin Chih-Yang,
Chao K.S. CliffordORCID
Subject
Cancer Research,Oncology
Reference50 articles.
1. Colorectal cancer statistics;Siegel;Ca - Cancer J. Clin.,2017
2. Colorectal cancer;Cunningham;Lancet,2010
3. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer;Goldberg;J. Clin. Oncol.,2004
4. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study;Saltz;J. Clin. Oncol.,2008
5. Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study;Fuchs;J. Clin. Oncol.,2007
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献